This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with lower respiratory track infections and see how it would impact clinical outcomes, antibiotics use, hospitalizations, ED clinicians find ways to improve health and medical care.
Lower Respiratory Tract Infection
This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with lower respiratory track infections and see how it would impact clinical outcomes, antibiotics use, hospitalizations, ED clinicians find ways to improve health and medical care.
The Impact of MeMed BV® on Management of Patients with Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
-
University of Florida-Jacksonville, Jacksonville, Florida, United States, 32209
University of Kansas Medical Center, Kansas City, Kansas, United States, 66160
Maimonides Medical Center, Brooklyn, New York, United States, 11219
Stony Brook University Hospital, Stony Brook, New York, United States, 11794
Philadelphia Thomas Jefferson Urgent Care, Philadelphia, Pennsylvania, United States, 19107
Medical University South Carolina, Charleston, South Carolina, United States, 29425
UT Southwestern Medical Center, Dallas, Texas, United States, 75390
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 99 Years
ALL
No
MeMed Diagnostics Ltd.,
2025-02-28